Floatz logo

LEUPROLIDE

Advanced Solid Tumors

OnKure, Inc.protein_peptidePhase 2Active
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
59/ 100

Competitive context

435 Active assets in the Advanced Solid Tumors cohort.

Asset / SponsorPhaseRating
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 4BB
FLUOROURACILUM
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
InSilico Medicine Hong Kong Limited
Phase 4BB
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB

View all 50 →

Same molecule, other indications

LEUPROLIDE is also rated in:

prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
prostate neoplasmDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →